We think there are several trends of interest. First, there is a lower death rate (P ¼ 0.04) with a higher eosinophil count. This supports a supposition made by the Srinivasan group that allergic enterocolitis is a more benign entity than NEC in general. Second, infants presenting with a higher eosinophil count show trends toward lower gestation and birth weights but later time of onset. These findings are consistent with preterm infants acquiring allergic enterocolitis over time postnatally (another postulate in evidence by their case study). Finally, in our data set, the infants we arbitrarily defined as having eosinophilia were likely substantially higher in their eosinophilia counts when compared with another report by Dr Juul et al.
Response to Drs Gordon and Clark
Journal of Perinatology (2011) 31, 298-299; doi:10.1038/jp. 2010.195 We appreciate the interest shown in our case report and the comments of Drs Gordon and Clark. 1 Gordon and Clark provide very interesting findings from the largest dataset of preterm infants with necrotizing enterocolitis (NEC) and their eosinophil counts at the time of the NEC diagnosis. In their dataset, in addition to the lack of feeding history (pathogenesis of allergic colitis is driven by dietary antigens), it is not clear whether stool examination for leucocytes was done in the subset of NEC patients categorized based on peripheral eosinophil count. The supposition about the allergic enterocolitis as a benign entity compared to NEC in general is based on lack of reported mortality rates in neonatal literature attributed to allergic enterocolitis as a clinical entity in itself and the dramatic improvement and non-progression of systemic symptomatology with removal of offending dietary antigen. Although a mortality rate of 16.8% relative to the higher mortality rate of 22% between low (<10) eosinophil count and higher eosinophil count (X10) groups with NEC may appear important, for a condition thought to be benign, even 16.8% mortality may be Abbreviation: NEC, necrotizing enterocolitis. Data are presented as n (%) or median (10-90th percentile).
Letters to the Editor considered high by many in neonatal practice, if this subset were to truly represent allergic enterocolitis. Of the three cytokines, interleukin-3 (IL-3), interleukin-5 (IL-5) and granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-5 (also known as differentiation-differentiation factor) is recognized as the most specific for the eosinophil lineage and responsible for selective differentiation of eosinophils. 2 However, correlation of serum concentrations of IL-5 and GM-CSF with the degree of severity of eosinophilia was not observed in the preterm neonates with eosinophilia in infection or necrotizing enterocolitis. 3 It is possible that IL-5 may be responsible for high eosinophilia in allergic enterocolitis as described in allergic conditions. 2 At baseline healthy conditions, eosinophils normally account for a small subset of circulating blood cells and primarily reside in the gastrointestinal tract. Recent literature on developmental biology of eosinophils and the numerous lines of evidence now are changing this perspective by showing that eosinophils are pleiotropic multifunctional leukocytes involved in initiation and propagation of diverse inflammatory responses, as well as acting as modulators of adaptive immunity by directly activating T cells. 4 As normal constituents of the mucosal immune system, particularly in the gastrointestinal tract, eosinophils are likely to have a physiological function. Eosinophils have been shown to have a role in organogenesis, tissue repair and remodeling, viral clearance and immune regulation in the local microenvironment. 5 We are intrigued by this observation of eosinophilia and the relationship to mortality in NEC and, with the new findings of the physiological functions of eosinophils, this could be explained based on severe eosinophilia conferring either additional protection or attenuating symptomatology and progression of a classical NEC.
In response to the questions based on the findings of Gordon and Clark, it is very likely that the field of neonatology is underestimating the incidence of allergic enterocolitis, especially with the significant overlap of the modified Bell's stage 1 and 2 A NEC (radiographic and gastrointestinal findings) with the clinical presentation of neonates with allergic enterocolitis. Dr Christensen et al. 6 have published the reference ranges from very large datasets on blood concentrations of eosinophils during the neonatal period, particularly among the extremely low birth weight neonates. Although they have excluded the neonates with a diagnosis of infection and NEC, it would be interesting to see if the eosinophil concentrations in their data among neonates with a diagnosis of allergic enterocolitis had any specific trend, and its utility in improving the diagnosis. In the exclusive human milk-based diet study by Sullivan et al., 7 one cannot exclude the possibility that the protective effect primarily was due to the avoidance of non-human milk-based protein in the exclusive human milk group. In a pilot study, Chuang et al. 8 have examined the systemic and mucosal immune compartments for evidence of bovine milk antigen sensitization in infants with NEC and demonstrated significant sensitization of cow's milk protein in NEC, at least in the systemic compartment (mixed T-helper type I and T-helper type II cytokine responses), with minimal mucosal activation in some cases. Their novel findings provide a potential mechanism for a direct contributory role of cow's milk protein in the pathogenesis of NEC and a possibility of allergic enterocolitis as a clinical entity that is part of the spectrum of acquired neonatal intestinal mucosal inflammatory disorder, with the extreme end being dietary antigentriggered NEC.
